Psychedelic assisted EMDR therapy (PsyA-EMDR) - A journey of stabilization
Description
There is a growing body of evidence to support the use of psychedelic medications to assist psychotherapy. Clinically, things have moved on significantly since the first wave of psychedelic assisted therapy techniques were developed in the 1950s/1960s. In recent years, the United Kingdom has become a hub of psychedelic research. UK based therapists are using expertise gained from working in clinical research settings to develop novel applications of EMDR therapy and embed these innovative ways of working into their clinical practice. This presentation introduces the emerging potential of EMDR as a psychedelic assisted therapy. It explores the synergistic benefits of combining evidence-based trauma focused toolkits with the healing potential of expanded states. It unpacks the importance of stabilization in paving the way to qualify EMDR as a psychedelic assisted therapy. Vignettes of case material from adverse psychedelic experiences in clinical research settings are used to unpack the developing PsyA-EMDR protocol.
Format
Conference
Language
English
Original Work Citation
Raine-Smith, H., & Rose, J. (2024, September). Psychedelic assisted EMDR therapy (PsyA-EMDR) - A journey of stabilization.Presentation at the at the 29th EMDR International Association Conference, Virtual
Collection
Citation
“Psychedelic assisted EMDR therapy (PsyA-EMDR) - A journey of stabilization,” Francine Shapiro Legacy Library, accessed January 12, 2026, https://francineshapirolibrary.omeka.net/items/show/29296.
